ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
WickedAwesome
|
49 |
15K |
6 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
49
|
15K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
WickedAwesome
|
49 |
15K |
2 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
49
|
15K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ and Promega sign Global EXO-NET Agreement
|
|
WickedAwesome
|
22 |
6.8K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
22
|
6.8K
|
2
|
|
Charts
|
RHY |
Re:
Where is RHY headed?
|
|
WickedAwesome
|
53 |
27K |
1 |
10/06/23 |
10/06/23 |
Charts
|
53
|
27K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
WickedAwesome
|
217 |
112K |
5 |
10/06/23 |
10/06/23 |
ASX - By Stock
|
217
|
112K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ to present new EXO-NET data at ISEV Annual Meeting
|
|
WickedAwesome
|
23 |
10K |
6 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
23
|
10K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
WickedAwesome
|
217 |
112K |
4 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
217
|
112K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Healthcare Conference Investor Presentation
|
|
WickedAwesome
|
16 |
8.3K |
1 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
16
|
8.3K
|
1
|
|
ASX - By Stock
|
AZI |
Re:
Ann: Altamin Executes JV Agreement for A$103M Funding Deal
|
|
WickedAwesome
|
3 |
2.5K |
3 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
3
|
2.5K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ to Develop SubB2M-Based Test on Nicoya SPR Platform
|
|
WickedAwesome
|
11 |
7.9K |
14 |
16/10/22 |
16/10/22 |
ASX - By Stock
|
11
|
7.9K
|
14
|
|
ASX - By Stock
|
GTG |
Re:
No wonder the SP is were it is!
|
|
WickedAwesome
|
14 |
4.6K |
1 |
20/08/22 |
20/08/22 |
ASX - By Stock
|
14
|
4.6K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to announce new TACTI-002 data at ASCO 2022
|
|
WickedAwesome
|
47 |
28K |
0 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
47
|
28K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: IIQ Investor Presentation
|
|
WickedAwesome
|
74 |
36K |
1 |
14/05/22 |
14/05/22 |
ASX - By Stock
|
74
|
36K
|
1
|
|
ASX - By Stock
|
AZI |
Re:
Ann: Letter to Shareholder & Notice of General Meeting
|
|
WickedAwesome
|
1 |
802 |
0 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
1
|
802
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Update on Legal Proceedings and BARD1 Autoantibody Program
|
|
WickedAwesome
|
56 |
26K |
23 |
10/04/22 |
10/04/22 |
ASX - By Stock
|
56
|
26K
|
23
|
|
ASX - By Stock
|
IIQ |
Re:
going up
|
|
WickedAwesome
|
14 |
7.9K |
2 |
16/03/22 |
16/03/22 |
ASX - By Stock
|
14
|
7.9K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Appointment of Non-Executive Director
|
|
WickedAwesome
|
22 |
8.6K |
1 |
27/02/22 |
27/02/22 |
ASX - By Stock
|
22
|
8.6K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4C & Quarterly Activities Report
|
|
WickedAwesome
|
22 |
10K |
7 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
22
|
10K
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ Awarded Additional BTB Funding to Develop SubB2M test
|
|
WickedAwesome
|
21 |
10K |
0 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
21
|
10K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ Awarded Additional BTB Funding to Develop SubB2M test
|
|
WickedAwesome
|
21 |
10K |
0 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
21
|
10K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: AGM Presentation
|
|
WickedAwesome
|
8 |
5.1K |
0 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
8
|
5.1K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: AGM Presentation
|
|
WickedAwesome
|
8 |
5.1K |
0 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
8
|
5.1K
|
0
|
|
ASX - By Stock
|
AZI |
Re:
Ann: Alta Zinc Investor Briefing
|
|
WickedAwesome
|
39 |
15K |
0 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
39
|
15K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: AGM Presentation
|
|
WickedAwesome
|
8 |
5.1K |
0 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
8
|
5.1K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Changes its Name to INOVIQ
|
|
WickedAwesome
|
10 |
5.1K |
1 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
10
|
5.1K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
WickedAwesome
|
1.4K |
553K |
0 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
1.4K
|
553K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep AGM 2021 - CEO's Presentation
|
|
WickedAwesome
|
6 |
3.2K |
4 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
6
|
3.2K
|
4
|
|
ASX - By Stock
|
GTG |
Re:
Ann: GTG Quarterly Business Update Presentation
|
|
WickedAwesome
|
11 |
6.3K |
0 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
11
|
6.3K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
under $1 ? R you kidding me?
|
|
WickedAwesome
|
48 |
19K |
7 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
48
|
19K
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
I am still hearing music - and getting louder
|
|
WickedAwesome
|
252 |
103K |
12 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
252
|
103K
|
12
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
WickedAwesome
|
1.4K |
553K |
1 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
1.4K
|
553K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
WickedAwesome
|
1.4K |
553K |
8 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
1.4K
|
553K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
CHECKPOINT INHIBITORS - What The?
|
|
WickedAwesome
|
30 |
12K |
0 |
11/09/21 |
11/09/21 |
ASX - By Stock
|
30
|
12K
|
0
|
|
ASX - By Stock
|
AZI |
Re:
Ann: Exploration Target Outlines Upside at Gorno
|
|
WickedAwesome
|
26 |
9.3K |
1 |
11/09/21 |
11/09/21 |
ASX - By Stock
|
26
|
9.3K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data
|
|
WickedAwesome
|
21 |
9.3K |
0 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
21
|
9.3K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Autoantibody Test Results for Ovarian Cancer Published
|
|
WickedAwesome
|
59 |
23K |
3 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
59
|
23K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Autoantibody Test Results for Ovarian Cancer Published
|
|
WickedAwesome
|
59 |
23K |
6 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
59
|
23K
|
6
|
|
ASX - By Stock
|
GTG |
Re:
Ann: GTG COVID-19 Risk Test launched in USA
|
|
WickedAwesome
|
52 |
17K |
0 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
52
|
17K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Demonstrates Feasibility of SubB2M-Based IHC Test
|
|
WickedAwesome
|
82 |
31K |
0 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
82
|
31K
|
0
|
|
ASX - By Stock
|
AZI |
Re:
Ann: Investor Presentation - November 2020
|
|
WickedAwesome
|
90 |
40K |
0 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
90
|
40K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
WickedAwesome
|
1.4K |
553K |
1 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
1.4K
|
553K
|
1
|
|
ASX - By Stock
|
AZI |
Re:
Ann: Further High-grade Results at Ponente
|
|
WickedAwesome
|
14 |
5.2K |
0 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
14
|
5.2K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
WickedAwesome
|
1.4K |
553K |
1 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
1.4K
|
553K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
WickedAwesome
|
1.4K |
553K |
0 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
1.4K
|
553K
|
0
|
|
ASX - By Stock
|
AZI |
Re:
Ann: March 2021 Quarterly Report and Appendix 5B
|
|
WickedAwesome
|
5 |
1.8K |
1 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
5
|
1.8K
|
1
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Pending testing results
|
|
WickedAwesome
|
306 |
143K |
2 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
306
|
143K
|
2
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Pending testing results
|
|
WickedAwesome
|
306 |
143K |
0 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
306
|
143K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
WickedAwesome
|
1.4K |
553K |
1 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
1.4K
|
553K
|
1
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Genetic Technologies appoints Mike Tonroe as CFO
|
|
WickedAwesome
|
17 |
7.8K |
0 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
17
|
7.8K
|
0
|
|
ASX - By Stock
|
GTG |
Re:
News: GTG Genetic Technologies Signs Multi-Year US Distribution Agreement For COVID Risk Test
|
|
WickedAwesome
|
31 |
15K |
0 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
31
|
15K
|
0
|
|